Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
The US SEC solicits regulatory opinions on 'new ETFs,' focusing on crypto and on-chain innovation products.

The US SEC solicits regulatory opinions on 'new ETFs,' focusing on crypto and on-chain innovation products.

Odaily星球日报Odaily星球日报2026/06/30 16:37
Show original

Odaily reported that the U.S. Securities and Exchange Commission (SEC) is publicly soliciting opinions on "novel exchange-traded funds (novel ETFs)" to evaluate their regulatory framework and market rule design. The SEC stated in its document that it continues to monitor the market's interest in various innovative products, including funds related to crypto assets, investment opportunities based on blockchain technology, and new types of financial derivatives such as "event contracts."

This request for comment is seen as a further early-stage exploration by the SEC regarding the boundaries of ETF regulation, especially as demand continues to grow for crypto ETFs, on-chain asset exposure products, and structured derivatives. Regulators are seeking a new balance between innovation and risk control. (The Block)

1
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race

Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.

智通财经•2026/11/12 01:07

Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity

Google DeepMind has released its AI model AlphaGenome 2, which is trained on maps of over 100 millions of cells and has nearly double the ability of its predecessor in identifying gene expression variations.

智通财经•2026/11/12 01:01
Google (GOOGL.US) DeepMind launches AlphaGenome 2: Capable of decoding DNA cells with nearly double the mutation identification capacity